Evidence map›Paper›PMID 29291614›Full record

ArticleJournal of neurogastroenterology and motility2018

Afifa Ait-Belgnaoui, Isabelle Payard, Claire Rolland, Cherryl Harkat, Viorica Braniste, Vassillia Théodorou, Thomas A Tompkins

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Journal of neurogastroenterology and motility, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06391216 (The Effect of Supplementation With Lactobacillus Helveticus R0052 and Bifidobacterium Longum R0175 Combination Probiotic on Mental Health Indices and Oral Microbiota Status in Healthy Volunteers Facing a Stressful Event), which is not on this map. Cited by 84 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06391216 nacompletednot on this mapstarted 2024, after this paper: background citation

The Effect of Supplementation With Lactobacillus Helveticus R0052 and Bifidobacterium Longum R0175 Combination Probiotic on Mental Health Indices and Oral Microbiota Status in Healthy Volunteers Facing a Stressful Event

TypeinterventionalSponsorMedical University of LodzRan2024 to 2024Enrolled100ConditionsHealthy, Stress-related Problem, Depression, AnxietyArmsLactobacillus helveticus R0052 and Bifidobacterium longum R0175, Placebo
3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 2 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Effect of Oral Administration ofInternational journal of environmental research and public health · 2022
    Trial
  6. Trial
  7. Health Benefits ofNutrients · 2019
    Trial
  8. Microbiome and chronic pelvic pain in women: a mini-review.Human reproduction (Oxford, England) · 2026
    Review
  9. Review
  10. Article
  11. Article
  12. Foods (Basel, Switzerland) · 2026
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Microorganisms · 2025
    Article
  19. Review
  20. Microbiome: A Key Regulator of Body-Brain Interactions.Advances in experimental medicine and biology · 2025
    Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 4 countries.

Afifa Ait-BelgnaouiNeuro-Gastroenterology and Nutrition team, TOXALIM, UMR 1331-INRA/INP/UPS, Toulouse, France.
Isabelle PayardNeuro-Gastroenterology and Nutrition team, TOXALIM, UMR 1331-INRA/INP/UPS, Toulouse, France.
Claire RollandLallemand Health Solutions, Montreal, Canada.
Cherryl HarkatNeuro-Gastroenterology and Nutrition team, TOXALIM, UMR 1331-INRA/INP/UPS, Toulouse, France.
Viorica BranisteDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
Vassillia ThéodorouNeuro-Gastroenterology and Nutrition team, TOXALIM, UMR 1331-INRA/INP/UPS, Toulouse, France.
Thomas A TompkinsLallemand Health Solutions, Montreal, Canada.
Université Toulouse III - Paul Sabatier · FRHealth Solutions (Sweden) · SEKarolinska Institutet · SELallemand (United Kingdom) · GBSolutions Inc. (Japan)Toxalim Research Centre in Food Toxicology · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsVisceral pain and hypothalamic-pituitary-adrenal axis (HPA) dysregulation is a common characteristic in irritable bowel syndrome (IBS) patients. Previously, we reported that a probiotic formulation (

methodsAfter a 2-week treatment with a combined probiotic formulation, or

resultsA pretreatment using the combination of probiotic formulation significantly reduces the chronic stress-induced visceral hypersensitivity respectively at 0.06, 0.08, and 0.10 mL CRD volume. However, a single probiotic (

conclusionThe combination of

Indexed as

Chronic stressGlucocorticoid receptorsProbioticsVisceral pain

Identifiers

PMID29291614
PMCPMC5753912
OpenAlexW2782131523

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.